Ceragenix and BexPharm Enter Into Distribution and Supply Agreement for EpiCeram(R)
February 22, 2010 09:46 ET
|
Ceragenix Pharmaceuticals
DENVER, CO, Feb 22, 2010 -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that it has entered...
Ceragenix and BioPro Enter into Distribution and Supply Agreement for EpiCeram(R)
January 07, 2010 06:33 ET
|
Ceragenix Pharmaceuticals
DENVER, Jan 07, 2010 -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology today announced that it has entered into an...
Second Partner Exercises Option for Exclusive Period to Negotiate Licensing Terms for CeraShield(TM) Antimicrobial Coating Application
October 26, 2009 06:46 ET
|
Ceragenix Pharmaceuticals
DENVER, Oct 26, 2009 -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today provided an update...
NIH Issues $2.87 Million Grant for Development of Ceragenin(TM)-Based Drug to Treat Clostridium difficile and Shigella Gastrointestinal Infections
September 09, 2009 06:34 ET
|
Ceragenix Pharmaceuticals
DENVER, Sep 09, 2009 -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that the National...
Partner Exercises Option for Exclusive Period to Negotiate Licensing Terms for CeraShield(TM) Antimicrobial Coating Application
September 01, 2009 06:33 ET
|
Ceragenix Pharmaceuticals
DENVER, Sep 01, 2009 -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company"), a medical device company focused on infectious disease and dermatology, today provided an update to a...
Ceragenix Completes Long-Term Antimicrobial Efficacy Test on Treated Silicone Medical Device
August 13, 2009 06:58 ET
|
Ceragenix Pharmaceuticals
DENVER, Aug 13, 2009 -- Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP) (the "Company"), a medical device company focused on infectious disease and dermatology, today provided an update on its...
Ceragenix and Megapharm Enter Into Distribution and Supply Agreement for EpiCeram(R)
July 27, 2009 07:21 ET
|
Ceragenix Pharmaceuticals
DENVER, Jul 27, 2009 -- Ceragenix Pharmaceuticals, Inc.("Ceragenix"), a medical device company focused on infectious disease and dermatology, today announced that it has entered into an exclusive...
Ceragenix and Nobel Biocare Enter into Option to License Agreement for Antimicrobial Technology
July 09, 2009 07:07 ET
|
Ceragenix Pharmaceuticals
DENVER, Jul 09, 2009 -- Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that it has entered into an exclusive...
National Jewish Health and Ceragenix Announce Compound Shows Promise for Treating Potentially Lethal Viral Infections
June 22, 2009 07:15 ET
|
Ceragenix Pharmaceuticals
DENVER, Jun 22, 2009 -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that researchers at...
Ceragenix and Davi Enter Into Distribution and Supply Agreement for EpiCeram(R)
May 19, 2009 07:12 ET
|
Ceragenix Pharmaceuticals
DENVER, May 19, 2009 -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology today announced that it has entered into an...